Grants that provide financial assistance for nutrition may help people with cystic fibrosis (CF) maintain a healthy body weight,…
Marisa Wexler, MS
Marisa holds a Master of Science in cellular and molecular pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. Her areas of expertise include cancer biology, immunology, and genetics, and she has worked as a science writing and communications intern for the Genetics Society of America.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Marisa Wexler, MS
Men with cystic fibrosis (CF) are generally knowledgeable about how their disease affects fertility, but they still want to…
Health Canada has approved the next-generation CFTR modulator therapy Alyftrek for people 6 years and older with cystic…
A lack of stability in a specific region of the CFTR protein may explain why certain people with cystic…
Two experimental CFTR modulator therapies being developed by Sionna Therapeutics are able to improve the function of the most…
Treating expectant mothers with CFTR modulators may help to reduce the risk of intestinal complications for babies with…
Undergraduate and graduate students in the U.S. who have cystic fibrosis (CF) are invited to apply for…
The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to RCT2100, an experimental treatment for cystic…
The Cystic Fibrosis Foundation is once again accepting applications for its Impact Grants, a funding initiative that offers…
Biomx has raised $12 million in financing to advance BX004, a phage therapy being developed to treat bacterial infections…